List View List View   Icon View Icon View

Showing items 1 - 5 of 5.

Add to Quick Collection   All 5 Results

  • First
  • Previous
  • 1
  • Next
  • Last
Title Author/Creator Date Full Text Reviewed
Add Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93 Pagani, Olivia; Gelber, Shari; Thürlimann, Beat; Fey, Martin F.; Murray, Elizabeth... More 2009 — Reviewed
Add Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-Year update of International Breast Cancer Study Group Trial 11-93 Thürlimann, Beat; Price, Karen N.; Goldhirsch, Aron; Gelber, Richard D.; Holmberg, Stig B.... More 2009 — Reviewed
Add Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial Rasmussen, Birgitte B.; Regan, Meredith M.; Braye, Stephen; Altermatt, Hans J.; Gelber, Richard D.... More 2008 — Reviewed
Add Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: Predictive value of centrally reviewed expression of estrogen and progesterone receptors - International Breast Cancer Study Group Viale, Giuseppe; Regan, Meredith M.; Braye, Stephen; Grigolato, Piergiovanni; Rusca, Tiziana... More 2008 — Reviewed
Add Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial Crivellari, Diana; Sun, Zhuoxin; Gelber, Richard D.; Colleoni, Marco; Lang, Istvan... More 2008 — Reviewed
  • First
  • Previous
  • 1
  • Next
  • Last
Author/Creator
Keyword